BioMerieux, which employs 800 people in Durham, manufactures blood culture bottles and instruments and reagents for bacterial testing. It expects increased business from biomedical firms that develop new diagnostic tests in response to new standards established 21st Century Cures Act.
BioMerieux, which employs 800 people in Durham, manufactures blood culture bottles and instruments and reagents for bacterial testing. It expects increased business from biomedical firms that develop new diagnostic tests in response to new standards established 21st Century Cures Act. N&O FILE PHOTO N&O FILE PHOTO
BioMerieux, which employs 800 people in Durham, manufactures blood culture bottles and instruments and reagents for bacterial testing. It expects increased business from biomedical firms that develop new diagnostic tests in response to new standards established 21st Century Cures Act. N&O FILE PHOTO N&O FILE PHOTO

Triangle biotech businesses big winners under new medical research law

December 20, 2016 5:26 PM

More Videos

  • 'I feel like I would have lost my life' without Smart NC, says patient

    Lisa Shank was denied coverage by her insurance company for treatment of a rare disease. State agency Smart NC helped her get the treatments she needed.